April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA94
Academic Journal
The article evaluates survival and the incidence of main post-transplant complications in orthotopic liver transplant recipients older than 60 years. From 1988 to October 2003, 767 adult liver transplants were performed at the Royal Free Hospital in London, England. Patients were divided in two groups according to age and compared. Older patients were more frequently transplant for hepatitis C and hepatocellular carcinoma. Following a transplantation, older patients had a significantly lower survival at 1 and 3 years.


Related Articles

  • Factors associated with recurrence and survival in liver transplant patients with HCC - a single center retrospective study. Hoyos, Sergio; Escobar, Jorge; Cardona, Doris; Guzmán, Carlos; Mena, Álvaro; Osorio, Germán; Pérez, Camilo; Restrepo, Juan C.; Correa, Gonzalo // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2015, Vol. 14 Issue 1, p58 

    Introduction. Hepatocellular carcinoma is the most common primary tumor of the liver and is diagnosed in more than a half million people worldwide each year. This study aims to assess factors associated with the recurrence and survival of patients with hepatocellular carcinoma and liver...

  • Longer transplant waits for HCC patients may be beneficial.  // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p23 

    The article discusses a research study which suggested the benefit of longer transplant waits for patients with hepatocellular carcinoma (HCC), presented at The Liver Meeting held in Washington on November 1-5, 2013.

  • US reports increase in liver cancer. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);03/20/99, Vol. 318 Issue 7186, p755 

    Reports on the increase incidence of hepatocellular carcinoma in the United States. Percentage increase from 1976 to 1995; Main risk factors associated with hepatocellular carcinoma; Belief of many older Americans with hepatitis C on how the disease is contracted.

  • The continuing challenge of hepatic cancer in Asia. Lai, E. C. H.; Lau, W. Y. // Surgeon (Edinburgh University Press);Jun2005, Vol. 3 Issue 3, p210 

    Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. The number of new cases is estimated to be 564,000 per year. About 80% of all cases are found in Asia. The goal of MCC management is "cancer control" — a reduction in its incidence and mortality as well as an...

  • Outcome of Hepatitis C Patients With and Without Hepatocellular Carcinoma Undergoing Liver Transplant. Min, Albert D.; Saxena, Romil; Thung, Swan N.; Atillasoy, Evren O.; Wolf, David C.; Sauter, Bernhard; Schwartz, Myron E.; Bodenheimer, Henry C. // American Journal of Gastroenterology;Nov1998, Vol. 93 Issue 11, p2148 

    Objective: Hepatitis C virus (HCV) infection is associated with development of hepatocellular carcinoma (HCC). The aim of this study was to examine clinical characteristics and outcome of patients with HCV with or without HCC undergoing liver transplant. Methods: We reviewed the charts of all 55...

  • Successful Embolization of Hepatocelluar Carcinoma With Yttrium-90 Glass Microspheres Prior to Liver Transplantation Kim, Dean Y.; Kwon, David S.; Salem, Riad; Ma, Chan K.; Abouljoud, Marwan S. // Journal of Gastrointestinal Surgery;Mar2006, Vol. 10 Issue 3, p413 

    We report a case of a patient with end-stage liver disease secondary to hepatitis C, complicated by a large hepatocellular carcinoma. Because of the size of the tumor exceeded the Milan criteria, he was not a candidate for liver transplantation. However, after two treatments with yttrium-90...

  • The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective. Menzin, Joseph; White, Leigh Ann; Nichols, Christine; Deniz, Baris // BMC Health Services Research;2012, Vol. 12 Issue 1, p459 

    Background: Chronic hepatitis C virus (HCV) may progress to advanced liver disease (ALD), including decompensated cirrhosis and/or hepatocellular carcinoma (HCC). ALD can lead to significant clinical and economic consequences, including liver transplantation. This study evaluated the health care...

  • Hepatitis C and liver transplantation. Brown Jr., Robert S. // Nature;8/18/2005, Vol. 436 Issue 7053, p973 

    Liver transplantation is a life-saving therapy to correct liver failure, portal hypertension and hepatocellular carcinoma arising from hepatitis C infection. But despite the successful use of living donors and improvements in immunosuppression and antiviral therapy, organ demand continues to...

  • Abnormalities identified in the liver after HCV eradication. Pockros, Paul J. // Infectious Disease News;Dec2011, Vol. 24 Issue 12, p19 

    The article discusses research from Japan which revealed histological abnormalities in noncancerous liver tissues of patients with hepatocellular cancer following hepatitis C (HCV) eradication.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics